Delivery Order SPE2DB22D3016-SPE2DB25FAAV6
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,179.81, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,186.29, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, with a final completion date of December 12, 2023. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $17,759.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, and has a completion date of March 4, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $5,172.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This federal contract award, valued at $12,764.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. This contract is a delivery order and has a firm fixed price pricing type, with a period of performance through July 10, 2024. The contract was not designated with a set-aside requirement, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,522.16 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 45 MG TABLET UU 28S. The contract has an ultimate completion date of February 5, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,567.48, is a Delivery Order contract for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a firm fixed price pricing type and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,962.91 firm fixed-price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,429.98, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on January 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,116.60 firm fixed-price delivery order contract is for the provision of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and was awarded on February 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...